Oncternal Therapeutics In... (ONCT)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Revenue 785.00K 1.49M 4.32M 3.38M 2.42M 2.52M 1.67M -2.51M - - - - 14.74M 60.61M 14.73M 13.53M 7.13M 7.50M 3.78M 1.87M - - - - -
Cost of Revenue 29.75M 179.00K 169.00K 12.00M 10.16M 46.00K 47.00K 2.51M 43.00K - - - 1.05M 768.00K 1.29M 649.00K 621.00K 773.00K 1.57M - - - - - -
Gross Profit -28.97M 1.31M 4.15M -8.63M -7.73M 2.48M 1.63M -5.02M -43.00K - - - 13.68M 59.84M 13.44M 12.88M 6.50M 6.73M 2.21M 1.87M - - - - -
Operating Income -41.71M -44.95M -31.37M -17.54M -33.11M -39.06M -30.66M -25.93M -21.84M -30.35M -43.60M -49.73M -33.69M 13.93M -46.65M -54.48M -45.50M -38.52M -38.56M -23.29M -14.34M -12.02M -8.15M -3.96M -819.00K
Interest Income 2.23M 777.00K 33.00K 16.00K 188.00K - - - - - - - - - 159.00K 2.71M 5.14M 3.01M 1.72M 946.00K 143.00K - 83.00K - -
Pretax Income -39.48M -44.17M -31.33M -17.23M -34.19M -38.42M -30.44M -17.72M -18.70M -39.41M -42.11M -49.75M -33.29M 15.29M -46.49M -51.78M -40.36M -35.51M -36.84M -5.68M -95.47M - - - -
Net Income -39.48M -43.39M -31.30M -17.21M -15.91M -38.42M -30.44M -17.72M -18.70M -39.41M -42.11M -27.07M -33.29M 15.29M -46.26M -51.78M -40.36M -35.51M -36.84M -22.35M -14.19M -11.87M -8.06M -3.81M -750.00K
Selling & General & Admin 12.75M 13.46M 11.60M 8.37M 7.29M 9.39M 9.19M 8.71M 8.23M 9.48M 11.28M 10.85M 15.44M 17.42M 27.75M 23.11M 13.50M 11.35M 9.85M 7.21M 3.51M 2.40M 2.23M 1.20M 256.00K
Research & Development 29.75M 32.98M 24.09M 12.54M 10.16M 29.67M 21.47M 17.23M 13.61M 20.87M 32.32M 38.89M 31.94M 28.50M 32.34M 44.26M 38.51M 33.90M 30.92M 17.95M 10.47M 9.29M 5.92M 2.68M 518.00K
Other Expenses -29.75M -1.49M -4.32M -3.38M -2.42M 641.00K 216.00K 46.00K 57.00K -259.00K 1.49M -19.00K 15.44M - - - 13.50M 11.35M 9.85M 7.21M 357.00K - - - -
Operating Expenses 12.75M 44.95M 31.37M 17.54M 15.02M 39.06M 30.66M 25.93M 21.84M 30.35M 43.60M 49.73M 47.38M 45.91M 60.09M 67.36M 52.01M 45.25M 40.77M 25.16M 14.34M 12.02M 8.15M 3.96M 819.00K
Interest Expense - - - - - - - - - - - - - - - - - - - - - - - - -
Selling & Marketing Expenses 200.00K - - - - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 42.50M 44.95M 31.37M 17.54M 15.02M 39.06M 30.66M 25.93M 21.84M 30.35M 43.60M 49.73M 48.43M 46.68M 61.38M 68.01M 52.63M 46.02M 42.34M 25.16M 14.34M 12.02M 8.15M 3.96M 819.00K
Income Tax - -777.00K -33.00K -16.00K -18.28M 641.00K -47.00K -8.19M -3.12M 8.70M -384.00K -8.82M -1.44M -2.94M -238.00K -1.56M 4.90M -72.03M 299.00K 17.25M -143.00K -156.00K 8.06M -150.00K -69.00K
Shares Outstanding (Basic) 2.94M 2.63M 2.47M 1.02M 516.45K 3.34M 2.49M 2.08M 2.01M 1.17M 900.82K 897.27K 819.42K 555.35K 520.22K 518.59K 499.14K 445.00K 371.18K 328.47K 110.50K 110.50K 110.68K 110.50K 110.50K
Shares Outstanding (Diluted) 2.94M 2.63M 2.47M 1.02M 516.45K 3.34M 2.49M 2.08M 2.11M 1.17M 900.82K 897.27K 819.42K 555.35K 520.22K 518.59K 499.14K 445.00K 371.18K 343.75K 110.50K 110.50K 110.68K 110.50K 110.50K
EPS (Basic) -13.43 -16.5 -12.69 -16.95 -30.81 -11.52 -12.22 -8.52 -9.33 -33.72 -46.75 -30.17 -40.63 27.30 -88.92 -99.85 -80.86 -79.8 -99.25 -68.04 -128.45 -107.39 -72.85 -34.5 -6.79
EPS (Diluted) -13.43 -16.5 -12.69 -16.95 -30.81 -11.52 -12.22 -8.52 -8.86 -33.72 -46.75 -30.17 -40.63 27.30 -88.92 -99.85 -80.86 -79.8 -99.25 -65.01 -128.45 -107.39 -72.85 -34.5 -6.79
EBITDA 2.23M -44.95M -31.37M -17.54M -33.11M 1.01M -30.39M -17.70M -18.66M -39.31M -41.73M -49.00M -34.09M 16.87M -44.71M -52.92M -45.50M -34.37M -38.56M -23.29M - -11.69M -8.15M -3.88M -774.00K
Depreciation & Amortization 41.71M 179.00K 169.00K 150.00K 15.02M 7.59M 47.00K 28.00K 43.00K 102.00K 384.00K 750.00K 1.04M 1.57M 1.78M 1.56M -4.90M -5.01M -299.00K -580.00K 357.00K 332.00K - 80.00K 45.00K